Efficiency of First-Trimester Uterine Artery Doppler, A-Disintegrin and Metalloprotease 12, Pregnancy-Associated Plasma Protein A, and Maternal Characteristics in the Prediction of Preeclampsia

被引:24
作者
Goetzinger, Katherine R. [1 ]
Zhong, Yan [1 ]
Cahill, Alison G. [1 ]
Odibo, Linda [1 ]
Macones, George A. [1 ]
Odibo, Anthony O. [1 ]
机构
[1] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
A-disintegrin and metalloprotease 12; pregnancy-associated plasma protein A; placental dysfunction; preeclampsia; uterine artery Doppler sonography; HUMAN CHORIONIC-GONADOTROPIN; FETAL-GROWTH RESTRICTION; HYPERTENSIVE DISORDERS; PAPP-A; WEEKS GESTATION; 1ST TRIMESTER; SERUM; COMPLICATIONS; POPULATION; ADAM12;
D O I
10.7863/ultra.32.9.1593
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objectives-The purpose of this study was to estimate the efficiency of first-trimester uterine artery Doppler, A-disintegrin and metalloprotease 12 (ADAM12), pregnancy-associated plasma protein A (PAPP-A), and maternal characteristics in the prediction of preeclampsia. Methods-We conducted a prospective cohort study of patients presenting for first-trimester aneuploidy screening between 11 and 14 weeks' gestation. Maternal serum. ADAM12 and PAPP-A levels were measured by an immunoassay, and mean uterine artery Doppler pulsatility indices were calculated. Outcomes of interest included preeclampsia, early preeclampsia (defined as requiring delivery at <34 weeks' gestation), and gestational hypertension. Logistic regression analysis was used to model the prediction of preeclampsia using ADAM12 multiples of the median (MoM), PAPP-A MoM, and uterine artery Doppler pulsatility index MoM, either individually or in combination. The sensitivity, specificity, and area under the receiver operating characteristic curves were used to compare the screening efficiency of the models using non-parametric U statistics. Results-Among 578 patients with complete outcome data, there were 54 cases of preeclampsia (9.3%) and 13 cases of early preeclampsia (2.2%). Median ADAM12 levels were significantly lower in patients who developed preeclampsia compared to those who did not (0.81 versus 1.01 MoM; P = .04). For a fixed false-positive rate of 10%, ADAM12, PAPP-A, and uterine artery Doppler parameters in combination with maternal characteristics identified 50%, 48%, and 52% of patients who developed preeclampsia, respectively. Combining these first-trimester parameters did not improve the predictive efficiency of the models. Conclusions-First-trimester ADAM12, PAPP-A, and uterine artery Doppler characteristics are not sufficiently predictive of preeclampsia. Combinations of these parameters do not further improve their screening efficiency.
引用
收藏
页码:1593 / 1600
页数:8
相关论文
共 21 条
[1]  
*AM COLL OBST GYN, 2002, ACOG PRACT B, V33
[2]  
[Anonymous], 2000, AM J OBSTET GYNECOL, V183, pS1
[3]   Oxygen and placental development during the first trimester: Implications for the pathophysiology of pre-eclampsia [J].
Caniggia, I ;
Winter, J ;
Lye, SJ ;
Post, M .
PLACENTA, 2000, 21 :S25-S30
[4]  
Confidential Enquiry Into Maternal and Child Health, 2008, PER MORT ENGL WAL NO
[5]   First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial) [J].
Dugoff, L ;
Hobbins, JC ;
Malone, FD ;
Porter, TF ;
Luthy, D ;
Comstock, CH ;
Hankins, G ;
Berkowitz, RL ;
Merkatz, I ;
Craigo, SD ;
Timor-Tritsch, IE ;
Carr, SR ;
Wolfe, HM ;
Vidaver, J ;
D'Alton, ME .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (04) :1446-1451
[6]   Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG [J].
Goetzinger, Katherine R. ;
Singla, Ashima ;
Gerkowicz, Sabrina ;
Dicke, Jeffrey M. ;
Gray, Diana L. ;
Odibo, Anthony O. .
PRENATAL DIAGNOSIS, 2010, 30 (12-13) :1138-1142
[7]   Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population [J].
Gómez, O ;
Martínez, JM ;
Figueras, F ;
Del Rio, M ;
Borobio, V ;
Puerto, B ;
Coll, O ;
Cararach, V ;
Vanrell, JA .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 26 (05) :490-494
[8]   Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia [J].
Laigaard, J ;
Sorensen, T ;
Placing, S ;
Holck, P ;
Fröhlich, C ;
Wojdemann, KR ;
Sundberg, K ;
Shalmi, AC ;
Tabor, A ;
Norgaard-Pedersen, B ;
Ottesen, B ;
Christiansen, M ;
Wewer, UM .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :144-149
[9]   ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3 [J].
Loechel, F ;
Fox, JW ;
Murphy, G ;
Albrechtsen, R ;
Wewer, UM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) :511-515
[10]   Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation [J].
Martin, AM ;
Bindra, R ;
Curcio, P ;
Cicero, S ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) :583-586